PayPay Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
PayPay Securities's BMY Position: Q3 2026 in Review
PayPay Securities reduced its Bristol-Myers Squibb (BMY) stake by 82% in Q3 2026, selling an estimated $10.7K and leaving 38 shares worth $2.37K. The position accounts for 0.08% of the portfolio, ranked #167.
PayPay Securities first reported a position in BMY in Q4 2022 and has held it in 16 quarters since. The position peaked at $11.9K in Q2 2026. 1,093 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- PayPay Securities held 38 shares of Bristol-Myers Squibb worth $2.37K as of Q3 2026.
- PayPay Securities sold 169 Bristol-Myers Squibb shares in Q3 2026, an estimated $10.7K.
- Bristol-Myers Squibb made up 0.08% of PayPay Securities's portfolio in Q3 2026, its #167 holding.
- PayPay Securities first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 16 quarters since.
- PayPay Securities's Bristol-Myers Squibb position peaked at $11.9K in Q2 2026.
- 1,093 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on PayPay Securities's 13F filing for Q3 2026, filed 27 Oct 2026.